Healthcare provider profile · identity verified

Michael E. Scovner, MD

Internal Medicine · POULTNEY, VT · NPI 1376615534

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	801	795
Shingrix	Varicella-Zoster Ge/As01b/Pf	490	385
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	314	312
Lisinopril	Lisinopril	244	61
Levothyroxine Sodium	Levothyroxine Sodium	174	41
Citalopram Hbr	Citalopram Hydrobromide	165	39
Omeprazole	Omeprazole	163	49
Oxycodone Hcl	Oxycodone Hcl	161	12
Albuterol Sulfate Hfa	Albuterol Sulfate	148	38
Losartan Potassium	Losartan Potassium	147	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	139	34
Alprazolam	Alprazolam	133	16
Famotidine	Famotidine	132	40
Tramadol Hcl	Tramadol Hcl	132	34
Zolpidem Tartrate	Zolpidem Tartrate	129	16
Atorvastatin Calcium	Atorvastatin Calcium	116	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	11
Gabapentin	Gabapentin	113	33
Metoprolol Succinate	Metoprolol Succinate	112	34
Prednisone	Prednisone	109	47
Arexvy	Rsvpref3 Antigen/As01e/Pf	105	105
Metoprolol Tartrate	Metoprolol Tartrate	104	27
Azithromycin	Azithromycin	102	72
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	101	suppressed
Simvastatin	Simvastatin	101	28
Hydrochlorothiazide	Hydrochlorothiazide	100	31
Lorazepam	Lorazepam	90	18
Metformin Hcl	Metformin Hcl	90	25
Amlodipine Besylate	Amlodipine Besylate	85	24
Ibuprofen	Ibuprofen	85	16
Levofloxacin	Levofloxacin	82	36
Pantoprazole Sodium	Pantoprazole Sodium	75	24
Eliquis	Apixaban	71	14
Meclizine Hcl	Meclizine Hcl	71	20
Diclofenac Sodium	Diclofenac Sodium	69	30
Duloxetine Hcl	Duloxetine Hcl	66	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	12
Glimepiride	Glimepiride	64	17
Cephalexin	Cephalexin	63	35
Torsemide	Torsemide	59	19
Fluticasone Propionate	Fluticasone Propionate	57	23
Clopidogrel	Clopidogrel Bisulfate	51	14
Amoxicillin	Amoxicillin	49	33
Clonazepam	Clonazepam	49	suppressed
Furosemide	Furosemide	49	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	37
Acetaminophen-Codeine	Acetaminophen With Codeine	46	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	46	30
Potassium Chloride	Potassium Chloride	44	15
Warfarin Sodium	Warfarin Sodium	44	suppressed
Penicillin V Potassium	Penicillin V Potassium	40	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	37	14
Allopurinol	Allopurinol	35	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	35	12
Farxiga	Dapagliflozin Propanediol	34	suppressed
Ondansetron Odt	Ondansetron	32	14
Clotrimazole	Clotrimazole	31	12
Zaleplon	Zaleplon	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	20
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	17
Trazodone Hcl	Trazodone Hcl	25	suppressed
Fluconazole	Fluconazole	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Mupirocin	Mupirocin	24	18
Sertraline Hcl	Sertraline Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Nystatin	Nystatin	22	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Nabumetone	Nabumetone	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Erythromycin	Erythromycin Base	17	13
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Ozempic	Semaglutide	17	suppressed
Atenolol	Atenolol	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	11
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error